This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke, Ahead of Print. BACKGROUND:Patient-reported outcome measures (PROMs) describe health status from the perspective of the patient. There is growing interest in incorporating PROMs into clinical trials, but the extent that such measures are used in contemporary stroke trials is uncertain.
BackgroundRacial and ethnic minority groups are at a higher stroke risk and have poor poststroke outcomes. Trials conducted in the United States, related to stroke and enrolling participants ≥18 years, were considered eligible. fold increase in reporting between 2010 and 2020. Overall, 60.1% were of Hispanic ethnicity.
Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included. Trend analyses for the years 2010–2019 revealed improved one-year MACE in patients with diabetes and CAD (year 2019 vs. 2010; 0.90; 0.81-1.00,
Stroke, Volume 56, Issue Suppl_1 , Page A129-A129, February 1, 2025. Background:The most common cause of arterial ischemic stroke (AIS) in previously healthy children, focal cerebral arteriopathy (FCA) can progress rapidly over days with worsening brain injury. Study neuroradiologist (M.W.) and pediatric vascular neurologist (H.J.F.)
Among patients receiving EVT, characteristics associated with age 80 years and the impact of age on EVT outcomes of discharge directly to home or acute inpatient rehabilitation, and independent ambulation at discharge were studied using multivariable analysis with generalized estimating equations.
Background The association between low socioeconomic status (SES) and worse surgical outcomes has become an emerging area of interest. Literature has demonstrated that carotid artery stenting (CAS) poses greater risk of postoperative complications, particularly stroke, than carotid endarterectomy (CEA). 2.30); p = 0.68].
Stroke, Volume 56, Issue Suppl_1 , Page AHUP1-AHUP1, February 1, 2025. Introduction:Identification of modifiable drivers of the disparity between neighborhood socioeconomic status (nSES) and strokeoutcomes remains elusive. We repeated the analyses stratified by stroke severity (NIHSS 5 or >5).Results:Among
Stroke, Volume 56, Issue Suppl_1 , Page ADP53-ADP53, February 1, 2025. Introduction:Identification of modifiable drivers of the disparity between neighborhood socioeconomic status (nSES) and strokeoutcomes remains elusive. We repeated the analyses stratified by stroke severity (NIHSS 5 or >5).Results:Among
Stroke: Vascular and Interventional Neurology, Volume 3, Issue 6 , November 1, 2023. BackgroundIt is unclear whether all patient subgroups with acute ischemic stroke have benefited from advances in reperfusion therapy. Secular changes were assessed per 5‐year cohorts (2000–2005, 2006–2010, 2011–2015, 2016–2020). to 29.8%.
Stroke, Ahead of Print. BACKGROUND:Although lower hemoglobin levels associate with worse intracerebral hemorrhage (ICH) outcomes, causal drivers for this relationship remain unclear. Similar relationships were seen with poor 6- and 12-month outcomes. Patients with systemic evidence of coagulopathy were excluded.
Stroke, Volume 55, Issue Suppl_1 , Page ATP219-ATP219, February 1, 2024. Introduction:The outcomes of mechanical thrombectomy (MT) for patients with acute ischemic stroke (AIS) caused by medium vessel occlusions (MeVOs) in different vessels remains unknown. years and 49 patients were female (46.7%). 95% confidence interval 1.71-62.2,
Stroke, Volume 55, Issue Suppl_1 , Page AWP205-AWP205, February 1, 2024. The aim of this study is to develop and validate a stroke prediction tool for outcome in MT for AIS patients with low ASPECTS using data from an ongoing international multicenter registry, the Stroke Thrombectomy and Aneurysm Registry (STAR).Methods:236
Stroke, Volume 56, Issue Suppl_1 , Page ADP16-ADP16, February 1, 2025. Introduction:The National Institutes of Health Stroke Scale (NIHSS) provides a clinical measure of stroke severity. Our outcome was differentially expressed levels of proteins in AIS patients classified by NIHSS scores.
Stroke, Volume 56, Issue Suppl_1 , Page ATP319-ATP319, February 1, 2025. Introduction:Residential segregation influences individual health outcomes across the life course. Census tract stroke prevalence was estimated using 2021 CDC PLACES data. Stroke prevalence was 1.59% (95% CI:1.50-1.69)
Stroke, Volume 55, Issue Suppl_1 , Page AWP210-AWP210, February 1, 2024. Background:Optimal Blood pressure management after thrombectomy for acute ischemic stroke and its association with clinical outcomes remains unclear. There were comparable rates of sICH (OR 1.12, 95% CI 0.75-1.67;
Stroke, Volume 55, Issue Suppl_1 , Page AWP192-AWP192, February 1, 2024. Introduction:Despite comparable outcomes for different frontline techniques in mechanical thrombectomy (MT) for acute ischemic stroke (AIS), there are sparse data regarding if and when to switch techniques if the first pass is unsuccessful.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP70-ATMP70, February 1, 2024. Previous studies suggest that the DHV sign was associated with early recurrent ischemic stroke in the anterior circulation secondary to intracranial atherosclerotic disease (ICAD). The primary outcome was mRS at discharge.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. This study aims to investigate the incidence, complications, and outcomes of SAH patients who develop HIT.MethodsICD‐9‐CM and ICD‐10‐CM codes were used to query the National Inpatient Sample for patients with SAH between 2010 and 2019.
Stroke, Volume 55, Issue Suppl_1 , Page A131-A131, February 1, 2024. The primary outcome was incident ischemic stroke. There were a total of 18 ischemic stroke events among those with LVI (6%) and 65 among those without LVI (3%). Further studies are needed to validate these CMR biomarkers of stroke risk.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionThe optimal management strategy for large vessel occlusion strokes (LVOS) from intracranial atherosclerotic disease (ICAD) remains debated. Safety outcomes were comparable with similar rates of symptomatic intracranial hemorrhage (sICH).ConclusionWhile
Stroke, Volume 55, Issue Suppl_1 , Page AWP204-AWP204, February 1, 2024. We aim to study the interplay between these factors in LCS and SCS patients.Methodology:Retrospective analysis of a comprehensive stroke center prospective database for patients with MCA-M1 or ICA-T occlusions who underwent MT between November 2010-March 2023.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue 6 , November 1, 2023. were male, and median baseline National Institutes of Health Stroke Scale was 17 [15–20]. Compared with standard medical care alone, EVT resulted in higher good outcome rates in patients with ICA‐I (42.9% versus 14.4%;P<0.001),
Stroke, Volume 55, Issue Suppl_1 , Page AWP148-AWP148, February 1, 2024. Background:The recognition of in-hospital strokes (IHS) and their subsequent interventions remain challenging. IHS do not have guideline-based efficiency metrics established. Only 1 in 5 IHS receive treatment within 60 minutes of symptom recognition time (SRT).
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. The AKI and non‐AKI groups were assessed for baseline clinical characteristics, interventions, complications, and outcomes. Thus, the objective of this study was to explore the predictors and ramifications of AKI in patients with aneurysmal SAH.
Stroke, Ahead of Print. Cervical carotid tortuosity and morphology were assessed in patients with Loeys-Dietz syndrome who underwent baseline computed tomography/magnetic resonance imaging of the cervical and cerebral arteries from 2010 to 2022. Cutoff values were determined per the Youden J index.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. MethodsFrom the prospectively collected SVIN Registry encompassing all consecutive patients treated with EVT from 12 centers across the US, we identified patients from 12/2010 – 12/2021. hour mark from the patients’ last known well time.
Stroke, Volume 55, Issue Suppl_1 , Page ATP94-ATP94, February 1, 2024. Intro & Background:Following the publication of the randomized clinical trials in 2015 and 2018 on endovascular stroke therapy (EVT), procedural utilization has increased. This dataset includes all LVO AIS patients that underwent EVT.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionFollowing the publication of the randomized clinical trials in 2015 and 2018 on endovascular stroke therapy (EVT), procedural utilization has increased. This dataset includes all LVO AIS patients that underwent EVT.
Stroke, Volume 54, Issue 12 , Page 3002-3011, December 1, 2023. BACKGROUND:There is limited information on the delivery of acute stroke therapies and secondary preventive measures and clinical outcomes over time in young adults with acute ischemic stroke. Outcome data were available from 2011.
Stroke, Volume 55, Issue Suppl_1 , Page AWMP42-AWMP42, February 1, 2024. Background:Prior studies have shown that individuals who have an in-hospital stroke are less likely to receive thrombolysis. Few studies have investigated the trends of in-hospital strokes over time, and many large databases do not include in-hospital strokes.
Stroke, Volume 56, Issue Suppl_1 , Page AWP93-AWP93, February 1, 2025. Introduction:Atrial fibrillation (AFib) is a major risk factor for ischemic stroke (IS). Methods:We used clinical and proteomics data of stroke patients aged 18 years lodged within a prospective plasma repository from 2010 to 2014.
Stroke, Volume 54, Issue 12 , Page 3054-3063, December 1, 2023. BACKGROUND:Patients with end-stage kidney disease undergoing dialysis are at significant risk of stroke. The primary outcome was incident acute ischemic stroke. Secondary outcomes included hemorrhagic stroke, acute coronary syndrome, and all-cause mortality.
Stroke, Volume 56, Issue 1 , Page 65-73, January 1, 2025. BACKGROUND:Socioeconomic disparities exist in acute stroke care as well as in long-term strokeoutcomes. METHODS:This was a nationwide register-based cohort study including all patients with incident ischemic or hemorrhagic stroke in Denmark from 2010 to 2020.
Stroke, Volume 55, Issue Suppl_1 , Page ATP1-ATP1, February 1, 2024. Background:There are conflicting data on temporal trends in subarachnoid hemorrhage (SAH) incidence and outcomes. Incidence rates were compared over time using linear regression after normalizing to 2010 census demographics.
Stroke, Volume 56, Issue Suppl_1 , Page ATP303-ATP303, February 1, 2025. Background:Prior studies indicate a relationship between migraine and MACE. Only patients who were seen for migraine in the Neurology Department were included. 6.82, p = 0.014), presence of atrial fibrillation (adj. OR: 1.34, 95% CI: 0.99-1.81,
Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)
Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)
The continuing trend reverses improvements achieved in the decade before the COVID-19 pandemic to reduce mortalities from heart disease and stroke , the leading causes of death in the United States. This was unfortunately the case with heart disease and stroke, which had been improving before the pandemic. from 2010 to 2019.
Stroke, Volume 56, Issue Suppl_1 , Page A46-A46, February 1, 2025. Introduction:The introduction of novel therapeutics into clinical practice could improve or worsen equity in health outcomes with respect to socioeconomic status, race, ethnicity, or sex. of potentially eligible patients] between 2010-2014 and 31,624 [32.6%
Cardiac Syncope ("True Syncope") Independent Predictors of Adverse Outcomes condensed from multiple studies 1. These premonitory symptoms were negative predictors of adverse outcomes in EGSYS. Abnormal ECG – looks for cardiac syncope. Hemoglobin less than 10 (SF rule) 6. Syncope with Exertion (EGSYS) 7. S yncope while supine (EGSYS) 8.
Background Differences in the clinical outcomes and level of risk among Asian versus non-Asian patients with atrial fibrillation (AF) have been sparsely investigated. Objective To provide a contemporary prospective comparison of outcomes for newly diagnosed patients with AF, between Asian and non-Asian regions. to 0.99), 0.52 (0.28
Objective To evaluate the impact of intraoperative neuromonitoring (IONM) on stroke and operative mortality after coronary and/or valvular operations. Methods This was an observational study of coronary and/or valvular heart operations from 2010 to 2021. vs 2.5%) and stroke (4.9% for stroke. for stroke.
This misinformation would have resulted in many thousands of people giving up their medication and suffering heart attacks and strokes as a result. Elinogrel feasibility trial (2010-2011) Novartis: £500K EMPA-KIDNEY (2017-ongoing) Boehringer Ingelheim: £106.3M Establishing Fuwai-Oxford research centre (2010-ongoing) Merck: £1.1M
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content